查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美侧向层析检测市场预测至 2030 年 - 区域分析 - 按产品类型、技术、测试类型、应用和最终用户
市场调查报告书
商品编码
1510734

北美侧向层析检测市场预测至 2030 年 - 区域分析 - 按产品类型、技术、测试类型、应用和最终用户

North America Lateral Flow Assay Market Forecast to 2030 - Regional Analysis - by Product Type, Technique, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 132 Pages | 订单完成后即时交付

价格

2022年北美侧流检测市值为36.8712亿美元，预计2030年将达到70.8953亿美元；预计2022年至2030年复合年增长率为8.5%。

越来越多地使用家庭检测试剂盒推动了北美侧向层析检测市场

侧向层析测定 (LFA) 是纸本测试，旨在检测复杂混合物（生物样品）中的分析物（条件特异性生物分子），其中样品放置在测试设备中的指定位置。这些测试会在 5-30 分钟内提供结果。侧流检测试剂盒在各种环境条件下均表现出稳定性，并具有较长的保质期。基于后来的流式检测的家庭测试允许用户测试自行收集的样本并获得结果，而无需经过培训的医疗专业人员的帮助。这些测试通常在柜檯出售。妊娠检测试剂盒是家庭侧流检测最常见的例子之一。此外，这些检测方法旨在诊断传染病、心血管疾病和爱滋病毒等耻辱性疾病。因此，这些疾病的盛行率不断上升，以及家庭医疗保健中越来越多地采用侧流检测，推动了侧流检测市场的成长。在 COVID-19 大流行期间，由于人们不愿意去医院或诊断实验室进行检测，许多公司引入了家用侧向层析检测来诊断 SARS-CoV-2 感染。

2020年10月，西门子医疗推出了CLINITEST快速COVID-19抗原自检，有助于在15分钟内检测出感染情况，以便更快地隔离感染者，避免疾病传播。

2020 年 7 月，BD 推出了便携式快速护理点抗原测试，可在 15 分钟内检测 SARS-CoV-2 感染。

2020 年 8 月，美国食品药物管理局 (FDA) 颁发了 Abbott BinaxNOW COVID-19 Ag 卡的紧急使用授权，这是一种检测该疾病的快速检测方法。 BinaxNOW 使用 Abbott 成熟的侧向层析技术，使其成为医疗保健提供者之间进行频繁大规模检测的友好且可靠的方法。

2020 年 9 月，罗氏针对接受 CE 标誌的市场推出了 SARS-CoV-2 快速抗原测试。

北美侧向层析检测市场概况

北美侧流检测市场分为美国、加拿大和墨西哥。 2022 年，美国占据北美最大的侧流检测市场份额。 。此外，诊断行业的技术进步可能成为未来几年北美侧流检测市场的主要驱动力。

美国侧流检测市场在北美占有重要份额。美国侧流检测市场的成长归因于对家用妊娠检测试剂盒的需求不断增长，以及爱滋病毒、肝炎、幽门螺旋桿菌和 COVID-19 等传染病发病率的迅速增加。据华盛顿大学医学院称，每年约有 2000 万美国女性依赖家庭妊娠检测，这促进了基于侧流检测的妊娠检测试剂盒的采用。

北美侧向层析检测市场收入及 2030 年预测（百万美元）

北美侧向层析检测市场区隔

北美侧流分析市场按产品类型、技术、测试类型、应用、最终用户和国家分类。

根据产品类型，北美侧流检测市场分为试剂盒和试剂以及侧流读取器。到 2022 年，试剂盒和试剂细分市场将占据更大的北美侧流检测市场。

就技术而言，北美侧流分析市场分为夹心分析、竞争分析和多重检测分析。 2022 年，夹心检测领域占据北美最大的侧流检测市场。

依测试类型，北美侧流检测市场分为侧流免疫检测和核酸侧流检测。 2022 年，侧流免疫分析领域将占据更大的北美侧流分析市场。

根据应用，北美侧流检测市场分为临床测试、兽医诊断、食品安全和环境测试以及药物开发和品质测试。 2022 年，临床测试领域占据北美最大的侧流检测市场。

按最终用户划分，北美侧流检测市场分为医院和诊所、诊断实验室、家庭护理、兽医诊所、製药和生物技术公司等。 2022 年，医院和诊所细分市场占据北美最大的侧流检测市场。

按国家/地区划分，北美侧流检测市场分为美国、加拿大和墨西哥。 2022 年，美国在北美侧流检测市场份额中占据主导地位。

F. Hoffmann-La Roche Ltd、Siemens Healthineers AG、Becton Dickinson and Co、PerkinElmer Inc、Hologic Inc、QIAGEN NV、bioMerieux SA、QuidelOrtho Corp、Abbott Laboratories、Merck KGaA、Bio-Rad Laboratories Inc 和 Thermo Fisher Inc.在北美侧流分析市场中营运的领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美侧向层析检测市场 - 主要产业动态

  • 北美侧向层析检测市场 - 主要产业动态
  • 市场驱动因素
    • 越来越多使用家庭检测试剂盒
    • 即时检测日益普及
  • 市场限制
    • 由于程序限制导致检测结果不一致
  • 市场机会
    • 侧向层析检测应用的不断发展
  • 未来的趋势
    • 侧流免疫分析中的智慧型手机使用和人工智慧集成
  • 影响分析

第 5 章：侧流分析市场 - 北美市场分析

  • 北美侧向层析检测市场收入，2020 - 2030

第 6 章：北美侧向层析检测市场分析 - 产品类型

  • 试剂盒和试剂
    • 概述
    • 试剂盒和试剂：北美侧向层析检测市场、收入和 2030 年预测
  • 侧向层析阅读器
    • 概述
    • 侧流层析读者：北美侧流层析检测市场、收入与 2030 年预测

第 7 章：北美侧向层析检测市场分析 - 技术

  • 夹心试验
    • 概述
    • 三明治检测：北美侧流检测市场、收入与 2030 年预测
  • 竞争性分析
    • 概述
    • 竞争分析：北美侧流分析市场、收入与 2030 年预测
  • 多重检测分析
    • 概述
    • 多重检测分析：北美侧流分析市场、收入与 2030 年预测

第 8 章：北美侧向层析检测市场分析 - 测试类型

  • 侧流免疫分析
    • 概述
    • 侧流免疫分析：北美侧流分析市场、收入与 2030 年预测
  • 核酸侧流层析检测
    • 概述
    • 核酸侧流分析：北美侧流分析市场、收入与 2030 年预测

第 9 章：北美侧流分析市场分析 - 应用

  • 临床测试
    • 概述
    • 临床测试：北美侧向层析检测市场、收入和 2030 年预测
  • 兽医诊断
    • 概述
    • 兽医诊断：北美侧向层析检测市场、收入和 2030 年预测
  • 食品安全与环境检测
    • 概述
    • 食品安全与环境检测：北美侧流检测市场、收入与 2030 年预测
  • 药物开发和品质测试
    • 概述
    • 药物开发与品质测试：北美侧向层析检测市场、收入与 2030 年预测

第 10 章：北美侧流侦测市场分析 - 最终用户

  • 医院和诊所
    • 概述
    • 医院和诊所：北美侧向层析检测市场、收入和 2030 年预测
  • 诊断实验室
    • 概述
    • 诊断实验室：北美侧向层析检测市场、收入和 2030 年预测
  • 居家护理
    • 概述
    • 家庭护理：北美侧向层析检测市场、收入和 2030 年预测
  • 兽医诊所
    • 概述
    • 兽医诊所：北美侧向层析检测市场、收入和 2030 年预测
  • 製药与生物技术公司
    • 概述
    • 製药和生物技术公司：北美侧向层析检测市场、收入和 2030 年预测
  • 其他的
    • 概述
    • 其他：北美侧向层析检测市场、收入和 2030 年预测

第 11 章：北美侧向层析检测市场 - 国家分析

  • 我们
  • 加拿大
  • 墨西哥

第 12 章：产业格局

  • 概述
  • 侧流分析市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Becton Dickinson and Co
  • PerkinElmer Inc
  • Hologic Inc
  • QIAGEN NV
  • bioMerieux SA
  • QuidelOrtho Corp
  • Abbott Laboratories
  • Merck KGaA
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc

第 14 章：附录

Product Code: BMIRE00028829

The North America lateral flow assay market was valued at US$ 3,687.12 million in 2022 and is expected to reach US$ 7,089.53 million by 2030; it is estimated to register a CAGR of 8.5% from 2022 to 2030.

Increasing Use of Home-Based Assay Kits Fuels North America Lateral Flow Assay Market

Lateral flow assays (LFA) are paper-based tests designed for the detection of analytes (condition-specific biomolecules) in complex mixtures (biological samples), wherein samples are placed in a designated spot in a test device. These tests provide results within 5-30 minutes. Lateral flow assay kits exhibit stability over various environmental conditions and prolonged shelf life. Home tests based on later flow assays permit users to test self-collected samples and get results without the assistance of a trained medical professional. These tests are generally sold over the counter. A pregnancy test kit is one of the most familiar examples of home-based lateral flow assays. Further, these assays are designed for the diagnosis of infectious diseases, cardiovascular diseases, and stigmatized diseases such as HIV. Therefore, the rising prevalence of these diseases and the increasing adoption of lateral flow assay testing in home healthcare drive the lateral flow assay market growth. During the COVID-19 pandemic, many companies introduced at-home lateral flow assays for the diagnosis of SARS-CoV-2 infection due to people's reluctance to visit hospitals or diagnostic labs for testing.

In October 2020, Siemens Healthineers launched the CLINITEST Rapid COVID-19 Antigen Self-Test that helps detect the infection in 15 minutes so that the infected individuals can be isolated sooner to avoid the disease spread.

In July 2020, BD Launched a portable, rapid point-of-care antigen test to detect SARS-CoV-2 infection in 15 minutes.

In August 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization for Abbott BinaxNOW COVID-19 Ag Card, a rapid test to detect the disease. BinaxNOW uses Abbott's proven lateral flow technology, making it a friendly and reliable method for frequent mass testing among healthcare providers.

In September 2020, Roche launched a SARS-CoV-2 Rapid Antigen Test for markets accepting the CE Mark.

North America Lateral Flow Assay Market Overview

North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US held the largest North America lateral flow assay market share in 2022. The market growth in the region is characterized by the growing prevalence of various diseases, government support for advanced diagnostics adoption, and increasing efforts in R&D and other activities undertaken by market players. In addition, technological advancements in the diagnosis industry are likely to be a major driver for the North America lateral flow assay market over the coming years.

The US lateral flow assay market holds a significant share in North America. The growth of the US lateral flow assay market is attributed to the growing demand for at-home kits for pregnancy testing and the rapidly increasing incidence of infectious diseases, such as HIV, Hepatitis, H. pylori, and COVID-19. According to the Washington University School of Medicine, annually, ~20 million women in the US rely on home pregnancy tests, which boosts the adoption of lateral flow assay-based pregnancy test kits.

North America Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)

North America Lateral Flow Assay Market Segmentation

The North America lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.

Based on product type, the North America lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger North America lateral flow assay market share in 2022.

In terms of technique, the North America lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest North America lateral flow assay market share in 2022.

By test type, the North America lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger North America lateral flow assay market share in 2022.

Based on application, the North America lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest North America lateral flow assay market share in 2022.

By end user, the North America lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest North America lateral flow assay market share in 2022.

By country, the North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US dominated the North America lateral flow assay market share in 2022.

F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America lateral flow assay market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Lateral Flow Assay Market - Key Industry Dynamics

  • 4.1 North America Lateral Flow Assay Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Use of Home-Based Assay Kits
    • 4.2.2 Rising Popularity of Point-of-Care Testing
  • 4.3 Market Restraints
    • 4.3.1 Inconsistent Assay Results Due to Procedural Limitations
  • 4.4 Market Opportunities
    • 4.4.1 Evolving Applications of Lateral Flow Assays
  • 4.5 Future Trends
    • 4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
  • 4.6 Impact analysis

5. Lateral Flow Assay Market - North America Market Analysis

  • 5.1 North America Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030

6. North America Lateral Flow Assay Market Analysis - Product Type

  • 6.1 Kits & Reagents
    • 6.1.1 Overview
    • 6.1.2 Kits & Reagents: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Lateral Flow Readers
    • 6.2.1 Overview
    • 6.2.2 Lateral Flow Readers: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Lateral Flow Assay Market Analysis - Technique

  • 7.1 Sandwich Assay
    • 7.1.1 Overview
    • 7.1.2 Sandwich Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Competitive Assays
    • 7.2.1 Overview
    • 7.2.2 Competitive Assays: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Multiplex Detection Assay
    • 7.3.1 Overview
    • 7.3.2 Multiplex Detection Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Lateral Flow Assay Market Analysis - Test Type

  • 8.1 Lateral Flow Immunoassay
    • 8.1.1 Overview
    • 8.1.2 Lateral Flow Immunoassay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Nucleic Acid Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Nucleic Acid Lateral Flow Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Lateral Flow Assay Market Analysis - Application

  • 9.1 Clinical Testing
    • 9.1.1 Overview
    • 9.1.2 Clinical Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Veterinary Diagnostics
    • 9.2.1 Overview
    • 9.2.2 Veterinary Diagnostics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Food Safety & Environment Testing
    • 9.3.1 Overview
    • 9.3.2 Food Safety & Environment Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Drug Development & Quality Testing
    • 9.4.1 Overview
    • 9.4.2 Drug Development & Quality Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

10. North America Lateral Flow Assay Market Analysis - End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Diagnostics Laboratories
    • 10.2.1 Overview
    • 10.2.2 Diagnostics Laboratories: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Homecare
    • 10.3.1 Overview
    • 10.3.2 Homecare: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Veterinary Clinics
    • 10.4.1 Overview
    • 10.4.2 Veterinary Clinics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Pharmaceutical & Biotechnology Companies
    • 10.5.1 Overview
    • 10.5.2 Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

11. North America Lateral Flow Assay Market - Country Analysis

  • 11.1 North America Lateral Flow Assay Market, Revenue and Forecast To 2030
    • 11.1.1 North America Lateral Flow Assay Market Revenue and Forecasts and Analysis - By Country
      • 11.1.1.1 US: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 US Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.1.3 US Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.1.1.4 US Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
        • 11.1.1.1.5 US Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.1.1.6 US Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.1.7 US Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.2 Canada: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.2.3 Canada Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Canada Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
        • 11.1.1.2.5 Canada Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.1.2.6 Canada Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.2.7 Canada Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Mexico: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.3.3 Mexico Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Mexico Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Mexico Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.1.3.6 Mexico Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.3.7 Mexico Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Lateral Flow Assay Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Siemens Healthineers AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Becton Dickinson and Co
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 PerkinElmer Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Hologic Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 QIAGEN NV
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 bioMerieux SA
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 QuidelOrtho Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Abbott Laboratories
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Merck KGaA
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Rad Laboratories Inc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Thermo Fisher Scientific Inc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Lateral Flow Assay Market Segmentation
  • Table 2. US Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Recent Organic Growth Strategies in the Lateral Flow Assay Market
  • Table 18. Recent Inorganic Growth Strategies in the Lateral Flow Assay Market
  • Table 19. Glossary of Terms, Lateral Flow Assay Market

List Of Figures

  • Figure 1. North America Lateral Flow Assay Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. North America Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030
  • Figure 4. North America Lateral Flow Assay Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 5. Kits & Reagents: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Lateral Flow Readers: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. North America Lateral Flow Assay Market Revenue Share, by Technique, 2022 & 2030 (%)
  • Figure 8. Process of Sandwich Lateral Flow Assay
  • Figure 9. Sandwich Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Process of Competitive Lateral Flow Assay
  • Figure 11. Competitive Assays: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Multiplex Detection Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. North America Lateral Flow Assay Market Revenue Share, by Test Type, 2022 & 2030 (%)
  • Figure 14. Lateral Flow Immunoassay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Nucleic Acid Lateral Flow Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. North America Lateral Flow Assay Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 17. Clinical Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Veterinary Diagnostics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Food Safety & Environment Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Drug Development & Quality Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. North America Lateral Flow Assay Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals and Clinics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Diagnostics Laboratories: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Homecare: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. Veterinary Clinics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 26. Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Others: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. North America Lateral Flow Assay Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. North America Lateral Flow Assay Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 30. US Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 31. Canada Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 32. Mexico Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 33. Growth Strategies in the Lateral Flow Assay Market